Evaluation of radio-immunotherapy sequence on immunological responses and clinical outcomes in patients with melanoma brain metastases (ELEKTRA)
In patients with melanoma brain metastases (MBM), a combination of radiotherapy (RT) with immune checkpoint inhibitors (ICI) is routinely used. However, the best sequence of radio-immunotherapy (RIT) remains unclear. In an exploratory phase 2 trial, MBM patients received RT (stereotactic or whole-br...
Main Authors: | Jessica C. Hassel, Timo E. Schank, Heiko Smetak, Jasmin Mühlbauer, Martin Salzmann, Devayani Machiraju, Christian Menzer, Kristin Lang, Laila König, Matthias F. Haefner, Ingrid Hülsmeyer, Christian Kohler, Rainer Spang, Alexander Enk, Jürgen Debus, Philipp Beckhove |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/2162402X.2022.2066609 |
Similar Items
-
Soluble immune checkpoints and T-cell subsets in blood as biomarkers for resistance to immunotherapy in melanoma patients
by: Devayani Machiraju, et al.
Published: (2021-01-01) -
Rapid disease progression on immune checkpoint inhibitors in young patients with stage IV melanoma
by: Devayani Machiraju, et al.
Published: (2023-01-01) -
Early Serum Markers for Immune Checkpoint Inhibitor Induced Hypophysitis in Melanoma Patients
by: Fouad Mitri, et al.
Published: (2024-03-01) -
Targeting the cMET pathway to enhance immunotherapeutic approaches for mUM patients
by: Devayani Machiraju, et al.
Published: (2023-01-01) -
Immune Responses against Disseminated Tumor Cells
by: Ling Peng, et al.
Published: (2021-05-01)